The inhibitory effect of elemene combined with tamoxifen on the breast cancer MCF-7 cell line

Journal of Xi'an Jiaotong University (Medical Sciences)

Volumn 28, Issue 1, 2007, Pages 74-77

  Zhou, Xiaojuan ^a   Zheng, Qi ^a   Zhao, Xiaoli ^a   Ma, Hailin ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Breast cancer; Elemene; Synergistic effect; Tamoxifen

Indexed keywords

ANTINEOPLASTIC AGENT; CHOLECYSTOKININ OCTAPEPTIDE; ELEMENE; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN CELL; MONOTHERAPY;

EID: 33947209077     PISSN: 16718259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Kelleher M, Miles D. The adjuvant treatment of breast cancer [J]. Int J Clin Pract, 2003, 57(3):195-199.
2. Chinese source
3. Tormey DC, Gray R, Falkson HC. Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer [J]. J Natl Cancer Inst, 1996, 88(24):1828-1833.
4. Chinese source
5. Chinese source
6. Chinese source
7. Chinese source
8. Chinese source